These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6126171)

  • 1. Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics.
    Nelson JC; Jatlow PI; Bock J; Quinlan DM; Bowers MB
    Arch Gen Psychiatry; 1982 Sep; 39(9):1055-61. PubMed ID: 6126171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of desipramine in depressed inpatients.
    Nelson JC
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):10-6. PubMed ID: 6384205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of desipramine in the medically ill.
    Cavanaugh SV
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):23-9. PubMed ID: 6480574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom exacerbation in psychotically depressed adolescents due to high desipramine plasma concentrations.
    Conrad CD; Kudler HS
    J Clin Psychopharmacol; 1986 Jun; 6(3):161-4. PubMed ID: 2872236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of 2-hydroxydesipramine plasma concentrations.
    Nelson JC; Bock JL; Jatlow PI
    Clin Pharmacol Ther; 1983 Feb; 33(2):183-9. PubMed ID: 6822031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective complaints during desipramine treatment. Relative importance of plasma drug concentrations and the severity of depression.
    Nelson JC; Jatlow PI; Quinlan DM
    Arch Gen Psychiatry; 1984 Jan; 41(1):55-9. PubMed ID: 6691785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desipramine hydroxylation: variability and effect of antipsychotic drugs.
    Bock JL; Nelson JC; Gray S; Jatlow PI
    Clin Pharmacol Ther; 1983 Mar; 33(3):322-8. PubMed ID: 6130865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response.
    Amsterdam JD; Brunswick DJ; Potter L; Winokur A; Rickels K
    Arch Gen Psychiatry; 1985 Apr; 42(4):361-4. PubMed ID: 3977553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of outpatients with desipramine.
    Rosenbaum JF
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):17-22. PubMed ID: 6384206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desipramine treatment of major depression in patients over 75 years of age.
    Nelson JC; Mazure CM; Jatlow PI
    J Clin Psychopharmacol; 1995 Apr; 15(2):99-105. PubMed ID: 7782495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroloeptic effect on desipramine steady-state plasma concentratins.
    Nelson JC; Jatlow PI
    Am J Psychiatry; 1980 Oct; 137(10):1232-4. PubMed ID: 6106391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desipramine-induced delirium at "subtherapeutic" concentrations: a case report.
    Kutcher SP; Shulman KI
    Can J Psychiatry; 1985 Aug; 30(5):368-9. PubMed ID: 4027862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiogram changes and therapeutic desipramine and 2-hydroxy-desipramine concentrations in elderly depressives.
    Kutcher SP; Reid K; Dubbin JD; Shulman KI
    Br J Psychiatry; 1986 Jun; 148():676-9. PubMed ID: 3779249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of desipramine in elderly women.
    Cutler NR; Zavadil AP; Eisdorfer C; Ross RJ; Potter WZ
    Am J Psychiatry; 1981 Sep; 138(9):1235-7. PubMed ID: 6791512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine.
    Suckow RF; Roose SP; Cooper TB
    Biol Psychiatry; 1992 Jan; 31(2):200-4. PubMed ID: 1737080
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonlinear desipramine kinetics: prevalence and importance.
    Nelson JC; Jatlow PI
    Clin Pharmacol Ther; 1987 Jun; 41(6):666-70. PubMed ID: 3581650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilocarpine for anticholinergic adverse effects associated with desipramine treatment.
    Salah RS; Cameron OG
    Am J Psychiatry; 1996 Apr; 153(4):579. PubMed ID: 8599415
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desipramine plasma concentration and antidepressant response.
    Nelson JC; Jatlow P; Quinlan DM; Bowers MB
    Arch Gen Psychiatry; 1982 Dec; 39(12):1419-22. PubMed ID: 7149903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.